Close

Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer

Go back to Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer
(NASDAQ: MNPR) Delayed: 0.65 +0.02 (3.17%)
Previous Close $0.63    52 Week High
Open $0.62    52 Week Low
Day High $0.66    P/E N/A 
Day Low $0.61    EPS
Volume 85,910